UBC experts on Pfizer antiviral treatment for COVID-19
Health Canada has authorized Pfizer’s PAXLOVID™ antiviral treatment for adults with mild to moderate COVID-19 who are at high risk of progressing to serious disease, including hospitalization or death. UBC experts are available to comment.
Jan 17, 2022